Xspray Pharma moves up to Nasdaq Stockholm’s Mid Cap-segment

Press release 2020-12-17

Xspray Pharma (publ) (Nasdaq Stockholm: XSPRAY) announces today that the company’s share will be moved to Nasdaq Stockholms Mid Cap segment on 4 January 2021

The move from the Small Cap is a result of Nasdaq’s annual review of the average market values within the Nordic market segments. The Mid Cap segment includes companies with a share value between 150 million EUR and 1 billion EUR. The move was announced by Nasdaq Stockholm on 17 December 2020.

Xspray Pharma has been listed on Nasdaq First North Growth Market since 2017, and the company’s shares has been traded on Nasdaq Stockholm since March 27, 2020. The company will move from the Small Cap segment to the Mid Cap segment after a strong share price development during 2020.